Intra-Cellular Beneish M Score

ITCI
 Stock
  

USD 53.81  1.28  2.44%   

This module uses fundamental data of Intra-Cellular Ther to approximate the value of its Beneish M Score. Intra-Cellular Ther M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Please see Intra-Cellular Ther Piotroski F Score and Intra-Cellular Ther Altman Z Score analysis.
  
Intra-Cellular Ther Debt to Equity Ratio is most likely to increase slightly in the upcoming years. The last year's value of Debt to Equity Ratio was reported at 0.17. Intra-Cellular Ther Accrued Expenses Turnover is most likely to increase slightly in the upcoming years. The last year's value of Accrued Expenses Turnover was reported at 4.01. The current Cash and Equivalents Turnover is estimated to increase to 1.18, while Return on Investment is projected to decrease to (57.36) .
At this time, it appears that Intra-Cellular Ther is an unlikely manipulator. The earnings manipulation may begin if Intra-Cellular Ther's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Intra-Cellular Ther executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Intra-Cellular Ther's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.66
Beneish M Score - Unlikely Manipulator
Elasticity of Receivables1.0Focus
Asset Quality1.21Focus
Expense Coverage1.0Focus
Gross Margin Strengs0.98Focus
Accruals Factor1.0Focus
Depreciation Resistance1.35Focus
Net Sales Growth1.08Focus
Financial Leverage Condition1.23Focus

Intra-Cellular Ther Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Intra-Cellular Ther's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Revenues90.4 M83.8 M
Significantly Up
Increasing
Slightly volatile
Selling General and Administrative Expense294.1 M272.6 M
Significantly Up
Increasing
Slightly volatile
Net Cash Flow from Operations(266.4 M)(259.5 M)
Fairly Down
Decreasing
Slightly volatile
Depreciation Amortization and Accretion425.1 K533.4 K
Significantly Down
Increasing
Slightly volatile
Total Assets435.4 M489.9 M
Fairly Down
Increasing
Slightly volatile
Investments334.8 M320 M
Sufficiently Up
Increasing
Slightly volatile
Investments Current334.8 M320 M
Sufficiently Up
Increasing
Slightly volatile
Property Plant and Equipment Net24.3 M22.6 M
Significantly Up
Increasing
Slightly volatile
Trade and Non Trade Receivables21.7 M20.2 M
Significantly Up
Increasing
Slightly volatile
Total Liabilities77.7 M72 M
Significantly Up
Increasing
Slightly volatile
Current Assets419.5 M467.3 M
Moderately Down
Increasing
Slightly volatile
Assets Non Current24.4 M22.6 M
Significantly Up
Increasing
Slightly volatile
Current Liabilities57.6 M53.4 M
Significantly Up
Increasing
Slightly volatile
Liabilities Non Current17.3 M18.7 M
Significantly Down
Increasing
Very volatile
Total Debt28.4 M25.4 M
Moderately Up
Increasing
Slightly volatile
Debt Current6.5 M6.7 M
Sufficiently Down
Increasing
Slightly volatile
Debt Non Current18.6 M18.7 M
Slightly Down
Decreasing
Very volatile
Operating Income(293.2 M)(285.7 M)
Fairly Down
Decreasing
Slightly volatile
Gross Margin0.890.904
Fairly Down
Decreasing
Slightly volatile

Intra-Cellular Ther Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Intra-Cellular Ther's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Intra-Cellular Ther in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Intra-Cellular Ther's degree of accounting gimmicks and manipulations.

About Intra-Cellular Ther Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Depreciation Amortization and Accretion

425,100

Intra-Cellular Ther Depreciation Amortization and Accretion is most likely to increase significantly in the upcoming years. The last year's value of Depreciation Amortization and Accretion was reported at 533,360

Intra-Cellular Ther Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Intra-Cellular Ther. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201720182019202020212022 (projected)
Revenues330.7 K245.84 K60.61 K22.81 M83.8 M90.42 M
Total Assets471.49 M357.21 M251.19 M717.31 M489.92 M435.39 M
Current Assets469.22 M355.44 M230.32 M690.9 M467.28 M419.46 M
Assets Non Current2.27 M1.77 M20.86 M26.41 M22.64 M24.43 M
Property Plant and Equipment Net1.14 M1.16 M20.51 M26.32 M22.55 M24.34 M
Depreciation Amortization and Accretion213.87 K368.67 K477.12 K528.12 K533.36 K425.1 K
Selling General and Administrative Expense23.67 M30.1 M64.95 M186.36 M272.61 M294.13 M
Total Liabilities17.05 M39.49 M56.18 M60.45 M72.03 M77.72 M
Current Liabilities14.21 M36.3 M36.22 M36.85 M53.36 M57.57 M
Liabilities Non Current2.84 M3.19 M19.96 M23.6 M18.68 M17.32 M
Operating Income(102.84 M)(162.27 M)(154.01 M)(231.23 M)(285.69 M)(293.21 M)
Net Cash Flow from Operations(80.49 M)(118.17 M)(127.98 M)(230.07 M)(259.54 M)(266.37 M)
Investments426.54 M292.58 M116.37 M597.4 M319.97 M334.8 M
Investments Current426.54 M292.58 M116.37 M597.4 M319.97 M334.8 M

About Intra-Cellular Ther Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Intra-Cellular Ther's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intra-Cellular Ther using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intra-Cellular Ther based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York. Intra-Cellular Ther operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 512 people.

Intra-Cellular Ther Investors Sentiment

The influence of Intra-Cellular Ther's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Intra-Cellular. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Intra-Cellular Ther's public news can be used to forecast risks associated with investment in Intra-Cellular. The trend in average sentiment can be used to explain how an investor holding Intra-Cellular can time the market purely based on public headlines and social activities around Intra-Cellular Ther. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Intra-Cellular Ther's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Intra-Cellular Ther's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Intra-Cellular Ther's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Intra-Cellular Ther.

Intra-Cellular Ther Implied Volatility

    
  52.77  
Intra-Cellular Ther's implied volatility exposes the market's sentiment of Intra-Cellular Ther stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Intra-Cellular Ther's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Intra-Cellular Ther stock will not fluctuate a lot when Intra-Cellular Ther's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Intra-Cellular Ther in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Intra-Cellular Ther's short interest history, or implied volatility extrapolated from Intra-Cellular Ther options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Intra-Cellular Ther using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Intra-Cellular Ther Piotroski F Score and Intra-Cellular Ther Altman Z Score analysis. Note that the Intra-Cellular Ther information on this page should be used as a complementary analysis to other Intra-Cellular Ther's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Intra-Cellular Stock analysis

When running Intra-Cellular Ther price analysis, check to measure Intra-Cellular Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intra-Cellular Ther is operating at the current time. Most of Intra-Cellular Ther's value examination focuses on studying past and present price action to predict the probability of Intra-Cellular Ther's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Intra-Cellular Ther's price. Additionally, you may evaluate how the addition of Intra-Cellular Ther to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Is Intra-Cellular Ther's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intra-Cellular Ther. If investors know Intra-Cellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intra-Cellular Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
5.1 B
Quarterly Revenue Growth YOY
1.77
Return On Assets
-0.28
Return On Equity
-0.5
The market value of Intra-Cellular Ther is measured differently than its book value, which is the value of Intra-Cellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intra-Cellular Ther's value that differs from its market value or its book value, called intrinsic value, which is Intra-Cellular Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intra-Cellular Ther's market value can be influenced by many factors that don't directly affect Intra-Cellular Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intra-Cellular Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine Intra-Cellular Ther value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intra-Cellular Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.